MedTrace Logo

Response to NonInvasive Mechanical Ventilation According to the Breathing Pattern

NCT01991535 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-03-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether breathing pattern (specifically the inspiratory time/total respiratory cycle value) has an influence over the response to the noninvasive mechanical ventilation.

Conditions

  • Neuromuscular Disorders
  • Chest Wall Disorders
  • Obesity Hypoventilation Syndrome (OHS)

Interventions

DEVICE

Spontaneous Ventilation Mode

Respiratory rate and duration of inspiration are controlled by the patient. Device model: Stellar 150® (ResMed, Australia).

DEVICE

Controlled Ventilation Mode

Ventilator maintains the positive end-expiratory pressure until the patient inspires. At that point, the ventilator reaches the support pressure in a predetermined time. The patient fixes the respiratory rate and the duration of inspiration, triggering all the cycles. Device model: Stellar 150® (ResMed, Australia).

DEVICE

Simulator Ventilation Mode

Ventilator maintains a continuous positive airway pressure during the entire cycle. Device model: Stellar 150® (ResMed, Australia).

Sponsors & Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Principal Investigators

  • Pedro A Anton Albisu, Medical Dr · Fundacio Gestio Sanitaria de l'Hospital de la Santa Creu i Sant Pau

  • Patricia Peñacoba Toribio, Physician · Fundacio Gestio Sanitaria de l'Hospital de la Santa Creu i Sant Pau

  • Macarena Segura, Physiotherapist · Fundacio Gestio Sanitaria de l'Hospital de la Santa Creu i Sant Pau

Study Design

Allocation
NA
Purpose
OTHER
Masking
SINGLE

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2016-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01991535 on ClinicalTrials.gov